Sort   by:  
 Page size 
UnknownThe c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease.
Not available
S-EPMC4007078 | biostudies-literature
UnknownTRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson's disease via CNTF.
Not available
S-EPMC4840550 | biostudies-literature
UnknownParkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.
Not available
S-EPMC6658849 | biostudies-literature
UnknownAndrogen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer.
Not available
S-EPMC4347241 | biostudies-literature
UnknownActivation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration.
Not available
S-EPMC4966315 | biostudies-literature
UnknownAdult Conditional Knockout of PGC-1α Leads to Loss of Dopamine Neurons.
Not available
S-EPMC5011687 | biostudies-literature
UnknownPARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency.
Not available
S-EPMC7057660 | biostudies-literature
GenomicsGAW16 Framingham and Simulated Data

Important links to apply for individual-level data

  1. Genetic Analysis Workshop
  2. Instructions to Request Authorized Access
phs000128.v3.p3 | EGA
UnknownOverexpression of Parkinson's Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology.
Not available
S-EPMC5355896 | biostudies-literature
UnknownTRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease.
Not available
S-EPMC8639668 | biostudies-literature
Sort   by:  
 Page size